Signaling Pathways - Prostaglandin EP receptors - RET - KDM - Myosin light chain kinases (MLCKs)
清除全部
- B4930 TC-E 5002Target: KDMSummary: 选择性组蛋白去甲基化酶KDM2/7亚家族抑制剂
- B6342 H-7 dihydrochlorideTarget: PKC|PKG|PKA|Myosin light chain kinases (MLCKs)Summary: 蛋白激酶抑制剂
- B7005 Prostaglandin E2中文名: 前列腺素E2Target: Prostaglandin EP receptorsSummary: 内源性前列腺素
- B3523 Fasudil中文名: 法舒地尔Target: ROCK|PKC|PKG|PKA|Myosin light chain kinases (MLCKs)Summary: 钙拮抗剂
- A2174 Lenvatinib (E7080)中文名: 乐伐替尼,仑伐替尼Target: VEGFR|PDGFR|RETSummary: VEGFR抑制剂
- A8236 Regorafenib4 Citation中文名: 瑞戈非尼Target: Raf|VEGFR|PDGFR|c-Kit|RETSummary: VEGFR/PDGFR/FGFR/mutant Kit/RET/Raf-1抑制剂
- A3626 ML-7 hydrochlorideTarget: Myosin light chain kinases (MLCKs)Summary: 肌球蛋白轻链激酶抑制剂
- A3348 Daminozide中文名: 丁酰肼Target: KDM|PHFSummary: KDM2A抑制剂
- A3194 AST 4871 CitationTarget: RETSummary: RET激酶抑制剂
- A4130 ENMD-2076Target: Aurora Kinases|FLT3|RET|Src|VEGFR3/FLT4|NTRK1/TRKA|CSF-1R/c-FmsSummary: Aurora A/Flt3的选择性抑制剂